We performed gene set enrichment analysis60 (GSEA) on samples with relatively high and relatively low levels of CDC20 using published gene signatures that stratify melanomas into two major subtypes: (1) highly proliferative/weakly metastatic and (2) weakly proliferative/highly metastatic (Supplemental Data 7)61,62. The gene discussed is CDC20; the disease is melanoma.